Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pace of Designer Drugs Increases Year on Year

Published: Monday, August 12, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Science needs to work hard to keep pace with clandestine designer drugs labs – that was the hard-hitting message delivered to delegates at AACC Clinical Lab Expo.

Leading testing firm, Randox Toxicology highlighted the problem and outlined the requirement for a rapid and comprehensive designer drugs testing system to tackle the issue. In recent years there has been a significant increase in new ‘designer drugs,’ also known as legal highs or bath salts. UN Drugs and Crime Office reported recently that member states have experienced a rise in numbers by more than 50 per cent in less than three years to 251 new designer drugs by mid-2012.

Speaking after addressing delegates, Randox Toxicology’s R&D team leader Dr Joanne Darragh said, “The current most prolific designer substances are synthetic cannabinoids (K2 and SPICE) and the synthetic cathinones, commonly referred to as ‘Bath Salts’ mirroring to a large extent the effects of the most popular traditional drugs. A recent development, however, is an increasing proportion of substances reported that are from less known and more obscure chemical groups. These compounds are often not detected among users who undergo regular drug screening due to the absence of a wider screening methodology.”

Randox Toxicology have developed the most rapid and comprehensive designer drug test in the world, as Dr Darragh further explained,

“Randox’s unique multiplex system allows us to detect 110 designer drugs, from one blood or urine sample.

“There is also a growing trend coming from the labs creating designer drugs to modify the molecular structure in order to navigate national and international bans. Development of new antibodies means that Randox Toxicology have the capability to rapidly meet changing trends in designer drug use, in fact, we can adapt our technology to test for new or modified drugs quicker than any other supplier in the world.”

“Thanks to Randox’s revolutionary biochip array technology, we can adapt any test in a completely unique and accurate way to produce the quickest result.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!